Back

Arterial-myocardial coupling in primary AL amyloidosis. A validation study of vascular involvement.

30 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Deeper insights into cardiomyocyte dysfunction Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Kimon Stamatelopoulos

National & Kapodistrian University of Athens, Athens (Greece)

9 More presentations in this session

Presentation thumbnail
Pnn deficiency alters expressions of calcium handling proteins and impairs nuclear envelope structure in cardiomyocytes
Professor S. Leu (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Whole-exome sequencing to identify causative variants in cases of sudden cardiac death below 50 years
Miss M. Modena (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Protosappanin a protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4/FTH1 axis-dependent ferroptosis
Professor M. Zhang (Harbin, CN)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic value of multiple circulating biomarkers for ventricular arrhythmias in patients with left ventricular hypertrabeculation
Doctor L. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Discovery of a cryptic founder variant in MYBPC3 associated with hypertrophic cardiomyopathy by promoting the most frequent natural missplicing events
Doctor M. Gallego Delgado (Salamanca, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Deeper insights into cardiomyocyte dysfunction

The Event

Event poster

ESC Congress 2024

30 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Incremental prognostic value of paradoxical blood pressure reduction after sympathetic stimulation in primary AL amyloidosis.
thumbnail
Congress Presentation
Cardiac remodelling and sympathetic activation in cardiac amyloidosis: insights from transcardiac blood sampling
thumbnail
Congress Presentation
Regression of cardiac light chain amyloid after chemotherapy and bone marrow transplantation. A case report

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources